Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis

Eiichi Tokuda, Yo Ichi Takei, Shinji Ohara, Noriko Fujiwara, Isao Hozumi, Yoshiaki Furukawa

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. Methods: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. Results: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson's disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. Conclusions: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations.

Original languageEnglish
Article number42
JournalMolecular Neurodegeneration
Volume14
Issue number1
DOIs
Publication statusPublished - 2019 Nov 19

Fingerprint

Cerebrospinal Fluid
Amyotrophic Lateral Sclerosis
Immunoprecipitation
Mutation
Progressive Supranuclear Palsy
Motor Neurons
Pathologic Processes
Mutant Proteins
Neurodegenerative Diseases
Parkinson Disease
Spinal Cord
Enzyme-Linked Immunosorbent Assay
Superoxide Dismutase-1
Amyotrophic lateral sclerosis 1
Antibodies
Genes

Keywords

  • Amyotrophic lateral sclerosis (ALS)
  • Cerebrospinal fluid (CSF)
  • Cu/Zn-superoxide dismutase (SOD1)
  • Protein misfolding

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. / Tokuda, Eiichi; Takei, Yo Ichi; Ohara, Shinji; Fujiwara, Noriko; Hozumi, Isao; Furukawa, Yoshiaki.

In: Molecular Neurodegeneration, Vol. 14, No. 1, 42, 19.11.2019.

Research output: Contribution to journalArticle

Tokuda, Eiichi ; Takei, Yo Ichi ; Ohara, Shinji ; Fujiwara, Noriko ; Hozumi, Isao ; Furukawa, Yoshiaki. / Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. In: Molecular Neurodegeneration. 2019 ; Vol. 14, No. 1.
@article{fc2a83e7587a47248df67ba6c9e2055a,
title = "Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis",
abstract = "Background: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. Methods: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. Results: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson's disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. Conclusions: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations.",
keywords = "Amyotrophic lateral sclerosis (ALS), Cerebrospinal fluid (CSF), Cu/Zn-superoxide dismutase (SOD1), Protein misfolding",
author = "Eiichi Tokuda and Takei, {Yo Ichi} and Shinji Ohara and Noriko Fujiwara and Isao Hozumi and Yoshiaki Furukawa",
year = "2019",
month = "11",
day = "19",
doi = "10.1186/s13024-019-0341-5",
language = "English",
volume = "14",
journal = "Molecular Neurodegeneration",
issn = "1750-1326",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis

AU - Tokuda, Eiichi

AU - Takei, Yo Ichi

AU - Ohara, Shinji

AU - Fujiwara, Noriko

AU - Hozumi, Isao

AU - Furukawa, Yoshiaki

PY - 2019/11/19

Y1 - 2019/11/19

N2 - Background: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. Methods: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. Results: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson's disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. Conclusions: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations.

AB - Background: A subset of familial forms of amyotrophic lateral sclerosis (ALS) are caused by mutations in the gene coding Cu/Zn-superoxide dismutase (SOD1). Mutant SOD1 proteins are susceptible to misfolding and abnormally accumulated in spinal cord, which is most severely affected in ALS. It, however, remains quite controversial whether misfolding of wild-type SOD1 is involved in more prevalent sporadic ALS (sALS) cases without SOD1 mutations. Methods: Cerebrospinal fluid (CSF) from patients including sALS as well as several other neurodegenerative diseases and non-neurodegenerative diseases was examined with an immunoprecipitation assay and a sandwich ELISA using antibodies specifically recognizing misfolded SOD1. Results: We found that wild-type SOD1 was misfolded in CSF from all sALS cases examined in this study. The misfolded SOD1 was also detected in CSF from a subset of Parkinson's disease and progressive supranuclear palsy, albeit with smaller amounts than those in sALS. Furthermore, the CSF samples containing the misfolded SOD1 exhibited significant toxicity toward motor neuron-like NSC-34 cells, which was ameliorated by removal of the misfolded wild-type SOD1 with immunoprecipitation. Conclusions: Taken together, we propose that misfolding of wild-type SOD1 in CSF is a common pathological process of ALS cases regardless of SOD1 mutations.

KW - Amyotrophic lateral sclerosis (ALS)

KW - Cerebrospinal fluid (CSF)

KW - Cu/Zn-superoxide dismutase (SOD1)

KW - Protein misfolding

UR - http://www.scopus.com/inward/record.url?scp=85075308447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075308447&partnerID=8YFLogxK

U2 - 10.1186/s13024-019-0341-5

DO - 10.1186/s13024-019-0341-5

M3 - Article

C2 - 31744522

AN - SCOPUS:85075308447

VL - 14

JO - Molecular Neurodegeneration

JF - Molecular Neurodegeneration

SN - 1750-1326

IS - 1

M1 - 42

ER -